Dramatic efficacy of cyclosporine A in macrophage activation syndrome [2]

Clinical and Experimental Rheumatology

Volumn 19, Issue 1, 2001, Pages 108-

  Ravelli, A ^a   Viola, S ^a   De Benedetti, F ^a   Magni Manzoni, S ^a   Tzialla, C ^a   Martini, A ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE;

CASE REPORT; CHILD; CLINICAL FEATURE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNOPATHOLOGY; LETTER; MACROPHAGE ACTIVATION SYNDROME; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; RHEUMATIC DISEASE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

CHILD; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MACROPHAGE ACTIVATION; MALE; SYNDROME; TREATMENT OUTCOME;

EID: 0035090790     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Macrophage activation syndrome in children with joint diseases
2. Macrophage activation syndrome and rheumatic disease in childhood: A report of four new cases
3. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine
4. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases
5. Bone marrow with reactive histiocytosis, hemophagocytosis and storage histocytes in systemic lupus erythematosus